Heart Failure Clinical Trial

Optimal Coronary Sinus Lead Implantation Using Intracardiac Impedography and Magnetic Resonance Imaging

Summary

Despite the dramatic effect of cardiac resynchronization therapy (CRT) on survival and morbidity in people with congestive heart failure, 50-70% of eligible patients do not respond to this intervention. There is retrospective evidence that placement of the left ventricular (LV) lead at the region of latest mechanical delay markedly improves response to CRT. However, there is no feasible way to gauge dyssynchrony at LV lead sites during CRT implantation. Impedance recordings from pacing lead tips allow for real-time assessment of mechanical motion and may represent a useful intraoperative tool to guide optimum placement of the LV lead during CRT implantation. This pilot trial will assess the use of intraoperative impedograms in humans to measure regional dyssynchrony at potential LV lead locations during CRT implantation.

View Full Description

Full Description

This is a clinical trial using intracardiac impedance signals (impedograms) to assess regional dyssynchrony at various sites of left ventricular (LV) lead placement in humans undergoing CRT device implantation. This study will test the following hypotheses during the funding period:

LV lead impedograms as an implant tool to place leads at sites of latest mechanical delay are feasible and correlate with other means of assessing dyssynchrony.
LV lead impedograms vary significantly depending on LV lead location.
There are several characteristics of LV lead impedograms that correlate with mechanical phenomena of the heart.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with NYHA class III or IV heart failure
LVEF ≤ 30%
QRS duration ≥ 120 ms

Exclusion Criteria:

Not a candidate for CRT implantation

Study is for people with:

Heart Failure

Estimated Enrollment:

38

Study ID:

NCT01129635

Recruitment Status:

Completed

Sponsor:

Emory University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Emory University Hospital
Atlanta Georgia, 30322, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

38

Study ID:

NCT01129635

Recruitment Status:

Completed

Sponsor:


Emory University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider